China Fines Four Firms For Fixing Allopurinol Prices
This article was originally published in PharmAsia News
Executive Summary
China’s drug price setting agency, the National Development and Reform Commission, has imposed fines on four pharma firms for coordinating and raising their prices for allopurinol products, and more crackdowns could be on the way, warned the commission.